TORONTO, April 17, 2023 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company“) (TSXV: KHRN) (OTCQX: KHRNF) is pleased announce that it has appointed Mr. Michael O’Connor as Chief Financial Officer of the Company, replacing the Company’s CFO, Ms. Helen Bellwood. Mr. O’Connor brings more than 30 years of operational, corporate finance, business development and corporate governance experience to Khiron. In
Cannabis Law Report
You must log in to post a comment.